Last Updated on February 12, 2022 by The Health Master
Dr Reddy’s Laboratories yesterday announced the launch of its authorised generic version of Par Pharmaceutical’s Vasostrict (vasopressin injection, USP) vials in the US market approved by the US Food and Drug Administration (USFDA), a company statement notified.
Dr Reddy’s vasopressin injection, USP, is supplied in a carton of 25 single-dose vials each containing vasopressin 1 mL at 20 units/mL, it further stated.
The vasostrict brand market had US sales of approximately $878.5 million MAT for the most recent twelve months ending in December 2021, according to IQVIA Health, concluded the statement.
USFDA gives nod to Lupin for Arformoterol Tartrate inhalation solution
Drug recall: Red Pill Capsules recalled due to this reason
Manufacturers of these 11 drugs to incorporate newly identified ADRs in packing
Govt releases new National List of Essential AYUSH Medicines: Download
Illegal Pharmaceutical unit unearthed by FDA, Police
First Nasal Spray for covid-19 treatment in India: 10 things to know
CDSCO gives nod to Wockhardt to export Sputnik vaccines
DCGI gives nod to manufacture vaccine against omicron for test and…
Overprescription back under spotlight: Doctors
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
